Second-quarter adjusted earnings per share reached USD 1.31. Abbott Laboratories stock costs EUR 87.

Stocks shattered records again Tuesday while oil surged, gold hit new highs, and crypto swung wildly, setting the stage for a fresh wave of analyst moves on names like Marvell, Intuitive Surgical, and NetApp that could reshape portfolios heading into the rest of the week.

Stocks shattered records again Tuesday while oil surged, gold hit new highs, and crypto swung wildly, setting the stage for a fresh wave of analyst moves on names like Marvell, Intuitive Surgical, and NetApp that could reshape portfolios heading into the rest of the week.

Stocks shattered records again Tuesday while oil surged, gold hit new highs, and crypto swung wildly, setting the stage for a fresh wave of analyst moves on names like Marvell, Intuitive Surgical, and NetApp that could reshape portfolios heading into the rest of the week.

Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.

Abbott Laboratories (NYSE:ABT) and Berry Street announced an exclusive US partnership to link glucose tracking with live nutrition coaching. The program pairs Abbott

In mid-September, the U.S. Department of Justice (DOJ) announced that Abbott Laboratories will pay nearly $385 million to resolve allegations that it caused false claims to be submitted to federal and state programs. The specific allegations, which initially were brought by three whistleblowers, are that Abbott failed to manufacture powdered infant formula at its Sturgis, […]

Abbott Laboratories (NYSE:ABT) is a business that is not showcasing any rapid growth trends. However, what makes it an attractive investment prospect is the company’s consistent track record of incremental dividends, with 411 consecutive quarterly payouts since 1924. Along with the company’s underlying business mix, it makes Abbott a suitable investment for dividend hunters. The […]

By most accounts, the Sturgis, Michigan plant served as the main source of powdered infant formula in the United States. It produced Similac and other brands that lined pediatrician waiting rooms and filled the cabinets of new parents who didn’t give the formula’s origins a second thought. At its height, it was the biggest facility

Abbott (ABT) closed the most recent trading day at $98.16, moving 1.94% from the previous trading session.

Abbott Laboratories (NYSE:ABT) readies the launch of Libre Duo, the first FDA-authorized dual glucose-ketone wearable.

Abbott said the FDA approved new U.S. capabilities for its CardioMEMS HF System. The update adds pat

Abbott Laboratories recently received FDA approval for upgraded capabilities on its CardioMEMS HF System and began U.S. commercialization of SimpleScreen CRC, an FDA approved blood based colorectal cancer screening test for average risk adults 45 and older. These launches extend Abbott Laboratories

Abbott Laboratories recently received FDA approval for upgraded capabilities on its CardioMEMS HF System and began U.S. commercialization of SimpleScreen CRC, an FDA approved blood based colorectal cancer screening test for average risk adults 45 and older. These launches extend Abbott Laboratories' reach in heart failure monitoring and early cancer detection by adding app based heart failure tools and a blood draw screening option that could influence long term demand patterns across its...

Both Medtronic and Abbott have dropped in 2026, and those declines reshuffled the math on yield, valuation, and long-term growth in ways that push retirement investors toward a clear but maybe surprising choice.

Abbott Laboratories stock was at USD 99.33 on October 6, 2026, 26.5 percent below its yearly high. S